Variant report
Variant | nsv976762 |
---|---|
Chromosome Location | chr12:10952631-10955306 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:61)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | GTF2F1 | chr12:10955299-10955391 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | JUN | chr12:10954330-10954332 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | JUND | chr12:10952605-10952844 | HepG2 | liver: | n/a | chr12:10952726-10952735 |
4 | MAFF | chr12:10954700-10954707 | HepG2 | liver: | n/a | n/a |
5 | STAT3 | chr12:10953440-10953866 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:10954529-10954579 | AoSMC | blood vessel: | n/a |
2 | chr12:10954529-10954579 | BE2_C | brain: | n/a |
3 | chr12:10954529-10954579 | GM12891 | blood: | n/a |
4 | chr12:10954529-10954579 | NT2-D1 | testis: | n/a |
5 | chr12:10954529-10954579 | BJ | skin: | n/a |
6 | chr12:10954529-10954579 | NH-A | brain: | n/a |
7 | chr12:10954529-10954579 | HAEpiC | amniotic membrane: | n/a |
8 | chr12:10954529-10954579 | RPTEC | kidney: | n/a |
9 | chr12:10954529-10954579 | HEK293 | kidney: | embryo |
10 | chr12:10954529-10954579 | K562 | blood: | n/a |
11 | chr12:10954529-10954579 | Hela-S3 | cervix: | n/a |
12 | chr12:10954529-10954579 | ProgFib | skin: | n/a |
13 | chr12:10954529-10954579 | HUVEC | blood vessel: | n/a |
14 | chr12:10954529-10954579 | PrEC | prostate: | n/a |
15 | chr12:10954529-10954579 | SK-N-SH_RA | brain: | n/a |
16 | chr12:10954529-10954579 | A549 | lung: | n/a |
17 | chr12:10954529-10954579 | NHBE | bronchial: | n/a |
18 | chr12:10954529-10954579 | IMR90 | lung: | fetal |
19 | chr12:10954529-10954579 | AG09319 | gingival: | n/a |
20 | chr12:10954529-10954579 | NB4 | blood: | n/a |
21 | chr12:10954529-10954579 | HCPEpiC | choroid plexus: | n/a |
22 | chr12:10954529-10954579 | LNCaP | prostate: | n/a |
23 | chr12:10954529-10954579 | GM19239 | blood: | n/a |
24 | chr12:10954529-10954579 | GM06990 | blood: | n/a |
25 | chr12:10954529-10954579 | HMEC | breast: | n/a |
26 | chr12:10954529-10954579 | PFSK-1 | brain: | n/a |
27 | chr12:10954529-10954579 | HRCEpiC | kidney: | n/a |
28 | chr12:10954529-10954579 | PANC-1 | pancreas: | n/a |
29 | chr12:10954529-10954579 | SKMC | muscle: | n/a |
30 | chr12:10954529-10954579 | GM12878 | blood: | n/a |
31 | chr12:10954529-10954579 | T-47D | breast: | n/a |
32 | chr12:10954529-10954579 | ECC-1 | luminal epithelium: | n/a |
33 | chr12:10954529-10954579 | HRE | kidney: | n/a |
34 | chr12:10954529-10954579 | SK-N-MC | brain: | n/a |
35 | chr12:10954529-10954579 | H1-hESC | embryonic stem cell: | embryo |
36 | chr12:10954529-10954579 | AG04450 | lung: | fetal |
37 | chr12:10954529-10954579 | MCF10A-Er-Src | breast: | n/a |
38 | chr12:10954529-10954579 | NHDF-neo | bronchial: | n/a |
39 | chr12:10954529-10954579 | HNPCEpiC | eye: | n/a |
40 | chr12:10954529-10954579 | CMK | blood: | n/a |
41 | chr12:10954529-10954579 | HL-60 | blood: | n/a |
42 | chr12:10954529-10954579 | HIPEpiC | eye: | n/a |
43 | chr12:10954529-10954579 | Jurkat | blood: | n/a |
44 | chr12:10954529-10954579 | AG09309 | skin: | n/a |
45 | chr12:10954529-10954579 | GM12892 | blood: | n/a |
46 | chr12:10954529-10954579 | MCF-7 | breast: | n/a |
47 | chr12:10954529-10954579 | HRPEpiC | eye: | n/a |
48 | chr12:10954529-10954579 | SK-N-SH | brain: | n/a |
49 | chr12:10954529-10954579 | HCM | heart: | n/a |
50 | chr12:10954529-10954579 | HEEpiC | esophagus: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:10951582..10953191-chr12:10954611..10956191,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
TAS2R7 | TF binding region |
TAS2R7 | CpG island |
ENSG00000121377 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs182390044 | chr12:10952642-10952643 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs144913041 | chr12:10952658-10952659 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs541600461 | chr12:10952666-10952667 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs561890902 | chr12:10952667-10952668 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs559620059 | chr12:10952679-10952680 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs539641989 | chr12:10952685-10952686 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs186254144 | chr12:10952686-10952687 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs375349139 | chr12:10952690-10952691 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs571124516 | chr12:10952703-10952704 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs564031890 | chr12:10952715-10952716 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs532956241 | chr12:10952784-10952785 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs546660514 | chr12:10952807-10952808 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs190575339 | chr12:10952835-10952836 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs532008538 | chr12:10952865-10952866 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs148632963 | chr12:10952866-10952867 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs568598939 | chr12:10952910-10952911 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs542562174 | chr12:10952912-10952913 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs34212148 | chr12:10953022-10953023 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs74060671 | chr12:10953025-10953026 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs115115000 | chr12:10953037-10953038 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs2588350 | chr12:10953057-10953058 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs552974167 | chr12:10953058-10953059 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs572920559 | chr12:10953113-10953114 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs10161483 | chr12:10953801-10953802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs560290757 | chr12:10953837-10953838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552118292 | chr12:10953840-10953841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs113551589 | chr12:10953885-10953886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs573674695 | chr12:10953913-10953914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs542298641 | chr12:10953920-10953921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs147102285 | chr12:10954019-10954020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556743128 | chr12:10954052-10954053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531135376 | chr12:10954074-10954075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187482140 | chr12:10954118-10954119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372662810 | chr12:10954158-10954159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374135400 | chr12:10954194-10954195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs147748080 | chr12:10954219-10954220 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs546643951 | chr12:10954246-10954247 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566674735 | chr12:10954251-10954252 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs267603295 | chr12:10954256-10954257 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs619381 | chr12:10954258-10954259 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs144773045 | chr12:10954283-10954284 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569111567 | chr12:10954304-10954305 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs537722865 | chr12:10954307-10954308 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138365374 | chr12:10954311-10954312 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs142826844 | chr12:10954330-10954331 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs558100889 | chr12:10954348-10954349 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs11838055 | chr12:10954382-10954383 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs3759251 | chr12:10954383-10954384 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs368353730 | chr12:10954399-10954400 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs143503106 | chr12:10954403-10954404 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 17690704 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 21965145 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Prostate cancer | 19156837 | CNVD |
Emphysema | 19352772 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16461572 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Melanoma | 20877625 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:10953800-10955200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr12:10953800-10955200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr12:10954000-10954200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr12:10954200-10954400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr12:10954200-10954600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr12:10954200-10955800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr12:10954200-10955800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr12:10954400-10954600 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr12:10954400-10955200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr12:10954400-10955200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
11 | chr12:10954400-10955600 | Enhancers | H1 Cell Line | embryonic stem cell |
12 | chr12:10954400-10955600 | Enhancers | H9 Cell Line | embryonic stem cell |
13 | chr12:10954400-10955600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr12:10954400-10955600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr12:10954400-10955600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr12:10954600-10955000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr12:10954600-10955400 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
18 | chr12:10954600-10955600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
19 | chr12:10955000-10955800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr12:10955200-10955400 | Flanking Active TSS | iPS-18 Cell Line | embryonic stem cell |
21 | chr12:10955200-10955600 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |